Imperagen raises £5 million to use quantum physics, AI on enzyme engineering; plus, Beauty booking startup Fresha hits $1 billion valuation

Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone. Also, beauty and wellness booking marketplace Fresha says it has raised $80 million investment from KKR’s Next Generation Technology Growth fund, KKR's growth equity arm. Learn more about your ad choices. Visit podcastchoices.com/adchoices